IndraLab
Statements
reach
"Overexpression of Smad7 not only inhibits Smad3 mediated renal fibrosis such as collagen matrix expression including epithelial-mesenchymal transition, but also blocks NF-kappaB-driven renal inflammation including accumulation of macrophages and T cells in both glomeruli and tubulointerstitium and upregulation of renal IL-1, TNFalpha, ICAM-1, and iNOS."
reach
"Based on the identification of downstream events of TGF-beta signaling transduction over the past several years, TGF-beta1 has been shown to activate Smad2 and Smad3, which are negatively regulated by Smad7, an inhibitor of TGF-beta signaling, through the ubiquitin-proteasome degradation mechanism [XREF_BIBR]."
reach
"In this study, we found that administration of AZ505 effectively inhibited phosphorylation of Smad3 and increased expression of Smad7 (an antagonist of Smad3) in vitro and in vivo, suggesting that SMYD2 is functionally linked to the TGF-β/Smad3 signaling pathway to induce its activation."
reach
"It has been recently announced to be discontinued the phase III trial; however, patients with Crohn 's disease have been treated with antisense oligonucleotides against SMAD7, which binds to the TGF-beta receptor, blocking TGF-beta1 signaling; inhibition of SMAD7 promotes TGF-beta-induced activation of SMAD2 and SMAD3 signal transducers, thereby activating TGF-beta1-mediated anti-inflammatory activities."
reach
"In line with the hypothesis that Smad2/3 signaling is responsible for the induction of SBE containing promoters by DeltaNp73, Smad7 which inhibits Smad2 and Smad3 activation XREF_BIBR, already at a very low concentration effectively prevented the DeltaNp73 stimulated increase in TGF-beta signaling in Hep3B cells (XREF_FIG)."